Found 61 with Last Name = 'painter' and Initial = 'gr' 
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: <1.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 3.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+4nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 8.00E+4nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+6nMAssay Description:Compounds were assayed for inhibition of NS5B-821 from HCV GT-1b Con-1. Reactions included purified recombinant enzyme, 1 u/L negative-strand HCV IRE...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 300nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 1.80E+3nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 2.70E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 1.50E+3nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 1.50E+3nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 5.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 1.08E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 3.45E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 5.60E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 6.44E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 4.02E+3nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 70nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 2.50E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 3.20E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 1.80E+3nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 3.80E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: 2.90E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
Affinity DataEC50: >7.50E+4nMAssay Description:Primary cytopathic effect (CPE) reduction assay. Four-concentration CPE inhibition assays are performed. Confluent or near-confluent cell culture mon...More data for this Ligand-Target Pair
